BMRCL’s airport line is 7 times unlucky
ByNaveen MenezesNaveen Menezes / Updated: Jan 29, 2021, 02:33 IST
.
As it awaits Central nod for 37-km project, the deadline for submission of bids has been pushed for the seventh time
For the seventh time in a row, the Bengaluru Metro Rail Corporation Ltd (
BMRCL) has postponed submission of bids for construction of the Metro corridor to Kempegowda International Airport (
KIA). Officials have been re-scheduling the date for submission of bids from September last year, in the hope that the
Union Government would clear the 37-km Phase II-B project soon. But, that was not to be.
On Wednesday, the BMRCL rescheduled the last date to submit the bids to April 3, over nine months after the tender was floated in July last year. It seems unlikely that officials will open the bids if the approval does not come by the end of 2020-21 financial year.
Srinagar-Jammu Highway Closed For 10 Days Post Ramban Bridge s Wall Collapses
A senior NHAI official said the road collapsed on its own and continuous rains might be one of the reasons. Representational Image Naseer Ganai 2021-01-13T11:52:46+05:30 Srinagar-Jammu Highway Closed For 10 Days Post Ramban Bridge s Wall Collapses outlookindia.com 2021-01-13T11:54:17+05:30
The authorities in Jammu and Kashmir have closed Srinagar-Jammu highway possibly for next ten days due to the sudden collapse of the retaining wall of a bridge at Kela Morh in Ramban. Hundreds of goods and other vehicles are stranded on the road.
A senior NHAI official said the road collapsed on its own and continuous rains might be one of the reasons. He also said that it is an approach road joining the bridge which has collapsed and the government has given directions to the BRO to construct an alternative bridge to resume traffic on the road.
Hindustan Construction Company (HCC) fell 1.13% to Rs 8.75 after the company said that Anil Chandani has resigned as the chief financial officer and key managerial person of the company with effect from 12 January 2021 due to personal reasons.Chandani will continue in his current position as chief financial officer and key managerial person till 15 January 2021.
The company reported a consolidated net loss of Rs 476.61 crore in Q2 FY21 as compared to a net loss of Rs 398.10 crore in Q2 FY20. Net sales during the quarter declined by 7.2% Y-o-Y to Rs 1,810.17 crore.
HCC is engaged in engineering and construction activities. It serves the infrastructure sectors of transportation, power and water.
W.e.f. 12 January 2021Hindustan Construction Company announced that Mr. Anil Chandani, Chief Financial Officer and Key Managerial Person of the Company has submitted letter of resignation from the services of the Company with effect from 12th January 2021 due to personal reasons. However, He will continue in his current position as Chief Financial Officer and Key Managerial Person till 15th January 2021.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continu
Updated Jan 08, 2021 | 10:27 IST
TCS to announce results today. Firm is expected to sustain the revenue momentum in the December 2020 quarter following pick up in the business activities Stocks to track in trade for January 8, 2021: Biocon, Tata Power, IDFC, ONGC, IndiGo, Hindustan Construction Company
Key Highlights
ONGC: Co approved issue of Up to Rs 1,500 crore worth non convertible debentures
Wendt India OFS gets demand at indicative price Rs 2,716.60
Biocon
The company’s biosimilars unit Biocon Biologics receives investment of Rs 555 crore from Abu Dhabi-based ADQ for a 1.80% minority stake. Deal values Biocon Biologics at a post-money valuation of about $4.17 billion.